Once preliminary purchasing agreements are fulfilled, molnupiravir’s price would be decided by the clinical experience, available evidence, and public opinion at the moment, specialists noted. An independent group of medical consultants monitoring the trial advisable stopping it early because the interim results had been so strong. Germany had always secured access to efficient COVID-19 remedies early; minister Jens Spahn advised an information convention when read more